A comprehensive review of the safety and effectiveness of this drug. If the drug
is not a Do Not Use product, information on adverse effects, drug interactions
and how to use the medication are included.
Search results below include drug profiles where your selected drug is a secondary subject of discussion
Drug Interactions: Warfarin (COUMADIN)
[hide all summaries]
(December 2007)
This article explains how to understand the International Normalized Ratio (INR), a test applied to a sample of a patient’s blood to determine how “thin” it is when you are using the blood thinner COUMADIN (warfarin). In addition, the article lists more than 50 drugs or dietary supplements that can interact harmfully with COUMADIN to cause the blood to be too thin (abnormal bleeding) or not thin enough which could result in lessening the effect of COUMADIN in stopping blood clot formation.
Don't Get Sold By Drug Ads on TV, Says Study
[hide all summaries]
(May 2007)
Not only does this study find that consumer drug ads are not educational, it also says that the ads may oversell the benefits of the drugs and could put the public health in danger. For example, of the 24 drugs included in this advertising study, seven are listed as Do Not Use in Worst Pills, Best Pills publications. You should not rely on direct-to-consumer television advertisements as a source of drug information.
Aspirin and Heart Attacks: Secondary Prevention, Yes; Primary Prevention, No
[hide all summaries]
(May 2004)
Aspirin is the preferred preventive treatment for those who have already had a heart attack (secondary prevention), at least for the majority of people who are not intolerant to aspirin. However, the lack of evidence of an aspirin benefit in the primary prevention of heart attack is clearly outweighed by the increased risk of bleeding from aspirin, and you should not use aspirin for the primary prevention of heart attacks.
Additional Information from Public Citizen
Search results below include Additional Information from Public Citizen where your selected drug is a secondary subject of discussion